Global HIV Prevention Coalition holds first meeting in Geneva, Switzerland, to find ways to strengthen and sustain political commitment for HIV prevention As part of global efforts to end AIDS as a public health threat, UNAIDS, the United Nations Population Fund (UNFPA) and partners have launched ...

HIV infections continue to occur at a rate of >2 million globally each year with women accounting for a little over 50% of infections. Although the overall incidence of HIV infections in the United States has decreased in recent years, certain populations remain particularly vulnerable, including racial/ethnic ...

For the six months of 2017, in all regions of Belarus, especially in Gomel region, the number of criminal prosecution increased drastically for cases of HIV-positive people by Article 157 of the Criminal Code of the Republic of Belarus (infecting a person with human immunodeficiency virus).

As part of a novel, once-daily, single-tablet HIV treatment, bictegravir could offer new option for people living with HIV in low- and middle-income countries Geneva, 4 October 2017 — The Medicines Patent Pool (MPP) today announced a licence with Gilead Sciences for bictegravir (BIC), now under ...

On October 6, the first meeting of working group on development of the "Transitional plan on state financing" was held in Yerevan. The working group includes the representatives of state agencies, international organizations, as well as representatives of civil sector and activists working in the field of combating HIV. "Unfortunately, the group lacks the representatives of the Ministry of Finance of Armenia, which, ...

In Kazakhstan, more frequent become the cases of ungrounded denial to assign the disability of HIV-positive children that leads to restrictions on equal access to basic standards of social services for all children affected by HIV/AIDS epidemic. Regarding the situation, the ECUO Parent Union officially addressed the Prime Minister of Kazakhstan, Baktyzhan Sagintayev, with a request to take this situation under his control. It can be solved based on the successful experience of South Kazakhstan area where ...

Andrey Yarovoi: expert of the regional expert group (REG) of the program "Partnership" implemented by the ECUO. Member of the ENPUD Coordination Council, a member of OST Association of Ukraine.   On September 18-19, in Bishkek, Kyrgyzstan, was held the National Conference "New challenges: HIV and TB", ...

On September 25-26, the national HIV programs managers of eastern European, central Asian and non-European Union/European Economic Area (EU/EEA) countries got together for a regional meeting held at the WHO European Office in Copenhagen. Vladimir Zhovtyak, ECUO President, as a representative of international PLWH community, participated ...

Participants of the regional meeting “The Coalition for Change”, that took place in Riga on September 22-24, signed a Memorandum of cooperation, understanding and establishing a regional organization to advocate for MSM+. The document was signed by representatives of five states: Germany, Poland, Latvia, Lithuania, ...

The World Heath Organization and UNAIDS have announced approval of a revolutionary pricing agreement that will facilitate access to the first affordable and all-purpose single-pill HIV regimen including Dolutegravir (DTG) for the public sector in low and middle-income countries. Its price will be around 75 ...

On September 22, a workshop for patient communities on accessibility of innovation in HIV treatment in Ukraine was held in Kyiv. During the workshop, influential international organizations – the EATG and the East Europe and Central Asia Union of People Living with HIV (ECUO) – ...

Igor Kilchevsky is an iconic figure in the PLWH community. His biography is a living illustration of HIV history and establishment of the civil society in Moldova. He went from being an activist who created a small non-governmental organization to being the leader of the ...

A study published in The Lancet HIV today showed that while the rate of newly reported HIV cases in Europe remained steady in younger people between 2004 and 2015, it increased by 2% each year overall in older people. With around 30 000 newly diagnosed ...

Janssen-Cilag International NV (Janssen) today announced that the European Commission has approved the use of Symtuza® (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single-tablet regimen (STR), for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older with ...

A three-pronged man-made antibody, created by French drugmaker Sanofi and U.S. scientists, could offer a new way to treat or prevent HIV, following successful tests in monkeys. Plans are under way to try the so-called trispecific antibody in initial human trials before the end of 2018, ...

To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir. Methods: All antiretroviral therapy (ART)-naïve and ART-experienced HIV-infected individuals from the Swiss HIV Cohort Study who initiated raltegravir or dolutegravir between 2006 and 2015 were investigated concerning treatment modification within the first ...

On September 25-26,the Regional Office for Europe of the World Health Organization convenes in Copenhagen a meeting of leaders of national HIV programs from Eastern Europe, Central Asia and non-EU/EEA countries. The purpose of this meeting is to support participating countries in the preparation or updating ...

A breakthrough pricing agreement has been announced which will accelerate the availability of the first affordable, generic, single-pill HIV treatment regimen containing dolutegravir (DTG) to public sector purchasers in low- and middle-income countries (LMICs) at around US$75 per person, per year. The agreement is expected to ...